Healthcare status of adults with pulmonary hypertension due to congenital heart disease

被引:1
|
作者
Busse, Amely J. [1 ,2 ]
Freilinger, Sebastian [1 ,3 ,4 ]
Eicken, Andreas [1 ]
Ewert, Peter [1 ]
Freiberger, Annika [1 ]
Huntgeburth, Michael [1 ]
Nagdyman, Nicole [1 ]
von Scheidt, Fabian [1 ]
Kaemmerer, Harald [1 ]
Weyand, Michael [2 ]
机构
[1] Tech Univ Munich, German Heart Ctr Munich, Clin Congenital Heart Dis & Pediat Cardiol, Munich, Germany
[2] Friedrich Alexander Univ, Univ Hosp Erlangen, Dept Cardiac Surg, Erlangen, Germany
[3] Tech Univ Munich, Dept Sport & Hlth Sci, Prevent Pediat, Munich, Germany
[4] German Heart Ctr Munich, Clin Congenital Heart Dis & Pediat Cardiol, Lazarettstr 36, D-80336 Munich, Germany
关键词
Congenital heart defects; pulmonary hypertension (PH); healthcare status; counselling needs; CHD; ARTERIAL-HYPERTENSION; SEPTAL-DEFECT;
D O I
10.21037/cdt-22-281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In the long-term course of treated and untreated congenital heart defects (CHD), pulmonary hypertension (PH) is one of the most relevant complications. Since PH carries a high risk for mortality and morbidity, it is important to improve the status of healthcare and medical knowledge regarding the affected patients. Therefore, this study aimed to determine the current medical care status, health-related knowledge, and specific counseling needs of adults with various forms of CHD (ACHD) who are at increased risk of developing PH, as well as those with manifest PH. Methods: In this retrospective cross-sectional study, a representative sample of 803 ACHD were analyzed. Patients were split into three groups based on CHD: low risk for PH, at risk for pre- or post-capillary PH, and manifest PH. Data collection took place between September 2017 until February 2018 in a tertiary care center for ACHD. Healthcare status and specific needs for information or advice were analyzed using a questionnaire designed by our group. The state of knowledge of the patients was assessed by comparing this questionnaire and the corresponding medical records. Results: Both patients with manifest PH (n=51) and patients at risk to develop PH (n=629) were insufficiently informed about their health status, specific care structures available to them, and patient organizations. About 50% of the patients had specific counseling needs, especially regarding physical capability and sports, daily stress, rehabilitation measures, and pregnancy. Only 47.8% of patients with manifest PH were aware of suffering from PH (P<0.001). In particular, the patients had large knowledge deficits regarding comorbidities related to their health condition. Conclusions: PH is a quantitatively and qualitatively underestimated residuum or sequela of CHD that significantly affects outcome and prognosis in ACHD. Multidisciplinary, structured, and specific counseling of affected individuals with corresponding risk constellations is urgently needed. A prerequisite for this is closer collaboration between primary care physicians (PCPs), such as general practitioners, family physicians, internists, or general cardiologists, and ACHD specialists. Targeted patient counseling and care could have a positive impact on the level of awareness of those affected and favorably influence their prognosis.
引用
收藏
页码:840 / +
页数:17
相关论文
共 50 条
  • [31] Adults with pulmonary arterial hypertension and congenital heart disease: When it rains, it pours
    Araujo, John J.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (03): : 336 - 338
  • [32] Efficacy and Safety of Bosentan for Pulmonary Arterial Hypertension in Adults With Congenital Heart Disease
    Monfredi, Oliver
    Griffiths, Linda
    Clarke, Bernard
    Mahadevan, Vaikom S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (10): : 1483 - 1488
  • [33] Carcinoembryonic antigen levels are increased with pulmonary output in pulmonary hypertension due to congenital heart disease
    Zi-yang, Yang
    Kaixun, Zhao
    Dongling, Luo
    Zhou, Yin
    Chengbin, Zhou
    Jimei, Chen
    Caojin, Zhang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (11)
  • [34] Pulmonary hypertension complicating congenital heart disease
    Rame J.E.
    Current Cardiology Reports, 2009, 11 (4) : 314 - 320
  • [35] STUDIES IN PULMONARY HYPERTENSION IN CONGENITAL HEART DISEASE
    BURCHELL, HB
    BRITISH HEART JOURNAL, 1959, 21 (02): : 255 - 262
  • [36] PULMONARY ARTERIAL HYPERTENSION IN CONGENITAL HEART DISEASE
    NADAS, AS
    RUDOLPH, AM
    GROSS, RE
    CIRCULATION, 1960, 22 (06) : 1041 - 1043
  • [37] Pulmonary arterial hypertension in congenital heart disease
    Ferrero, Paolo
    Krishnathasan, Kaushiga
    Constantine, Andrew
    Chessa, Massimo
    Dimopoulos, Konstantinos
    HEART, 2024, 110 (18) : 1145 - 1152
  • [38] Pulmonary hypertension associated with congenital heart disease
    He, Siyi
    Qian, Hong
    Xu, Xingbo
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [39] The pathophysiology of pulmonary hypertension in congenital heart disease
    Steinhorn, RH
    Fineman, JR
    ARTIFICIAL ORGANS, 1999, 23 (11) : 970 - 974
  • [40] Functional parameters or biomarkers: which best predicts prognosis in adults with pulmonary arterial hypertension due to congenital heart disease?
    Blok, I. M.
    Van Riel, A. C. M. J.
    Schuuring, M. J.
    De Bruin-Bon, R. H. A. C. M.
    Van Dijk, A. P. J.
    Hoendermis, E. S.
    Zwinderman, A. H.
    Mulder, B. J. M.
    Bouma, B. J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 458 - 459